Boothbay Fund Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Boothbay Fund Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-16,161	Closed	-$201	–	1050
2016 Q4	$201	Buy	+16,161	New	+$195K	0.05%	604

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Boothbay Fund Management's ARIA Position: Q1 2017 in Review

Boothbay Fund Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 16,161 shares — an estimated $201 sold.

Boothbay Fund Management first reported a position in ARIA in Q4 2016 and held it in 1 quarter. The position peaked at $201 in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Boothbay Fund Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Boothbay Fund Management sold 16,161 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $201.
Boothbay Fund Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
Boothbay Fund Management's Ariad Pharmaceuticals Inc position peaked at $201 in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Boothbay Fund Management's 13F filing for Q1 2017, filed 15 May 2017.